Skip to main content

The Role of the Nervous System in the Regulation of Liver Cytochrome P450

Buy Article:

$68.00 + tax (Refund Policy)

The central and peripheral nervous systems are important factors influencing the functioning of liver cytochrome P450 (CYP). It has been shown that changes in the brain monoaminergic systems affect liver cytochrome P450 (CYP) expression (CYP1A, CYP2B, CYP2C11 and CYP3A). The brain dopaminergic system has been established as an important center regulating the liver CYP. This regulation proceeds via the tuberoinfundibular pathway and the dopaminergic D2 receptors of the pituitary, as well as the mesolimbic pathway engaging the D2 receptors of the nucleus accumbens (conveying a message to the paraventricular nucleus of the hypothalamus). These two dopaminergic pathways stimulate the secretion of pituitary hormones, which directly (GH) or indirectly (ACTH, TSH) activate hepatic nuclear/ cytosolic receptors controlling CYP genes. Recent preliminary studies with selective noradrenaline or serotonin neurotoxins suggest also involvement of the brain noradrenergic and serotonergic systems in the regulation of liver CYP. Moreover, the influence of the peripheral nervous system involving several neurotransmitters (acetylcholine, noradrenaline, adrenaline, dopamine, serotonin) on liver function may also be important for the physiological regulation of hepatic CYP activity. The hypothalamus controls liver function not only by releasing hormones from the pituitary gland but also by stimulating the autonomic sympathetic and parasympathetic projections to the liver. In addition to direct neural connections, the autonomic nervous system can indirectly affect liver function via the hypothalamus-adrenal axis and the hypothalamus- pancreas axis. Therefore, the estimation of neuroactive drug action on hepatic CYP requires an in vivo model which allows the central neuroendocrine and peripheral autonomic regulation of genes coding for CYP isoforms.





Keywords: Brain; autonomic nervous system; cytokines; dopaminergic system; hypothalamus-adrenal axis; liver cytochrome P450; noradrenergic system; pituitary hormones; serotonergic system; tuberoinfundibular pathway

Document Type: Research Article

Publication date: 01 February 2011

More about this publication?
  • Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism and disposition. The journal serves as an international forum for the publication of timely reviews in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments. The journal covers the following areas:

    In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; recent developments for the identification of drug metabolites and adducts.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content